Kapusta LR - Search Results

1

Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.

Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM. Tsihlias J, et al. Among authors: kapusta lr. Cancer Res. 1998 Feb 1;58(3):542-8. Cancer Res. 1998. PMID: 9458103

2

Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.

Zhang W, Kapusta LR, Slingerland JM, Klotz LH. Zhang W, et al. Among authors: kapusta lr. Cancer Res. 1998 Feb 15;58(4):619-21. Cancer Res. 1998. PMID: 9485010

3

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.

Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM. Catzavelos C, et al. Nat Med. 1997 Feb;3(2):227-30. doi: 10.1038/nm0297-227. Nat Med. 1997. PMID: 9018244

4

The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.

Tsihlias J, Kapusta L, Slingerland J. Tsihlias J, et al. Annu Rev Med. 1999;50:401-23. doi: 10.1146/annurev.med.50.1.401. Annu Rev Med. 1999. PMID: 10073286 Review.

5

p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder.

Fleshner N, Kapusta L, Ezer D, Herschorn S, Klotz L. Fleshner N, et al. J Urol. 2000 Oct;164(4):1177-82. J Urol. 2000. PMID: 10992361

6

PSA doubling time of prostate carcinoma managed with watchful observation alone.

Choo R, DeBoer G, Klotz L, Danjoux C, Morton GC, Rakovitch E, Fleshner N, Bunting P, Kapusta L, Hruby G. Choo R, et al. Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):615-20. doi: 10.1016/s0360-3016(01)01511-5. Int J Radiat Oncol Biol Phys. 2001. PMID: 11395227 Clinical Trial.

7

The role of DNA flow and image cytometry in the evaluation of body cavity fluids.

Kapusta L, Zbieranowski I, Demianiuk C, Murray D. Kapusta L, et al. Anal Quant Cytol Histol. 1991 Jun;13(3):187-92. Anal Quant Cytol Histol. 1991. PMID: 1910419

8

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

Chappuis PO, Kapusta L, Bégin LR, Wong N, Brunet JS, Narod SA, Slingerland J, Foulkes WD. Chappuis PO, et al. Among authors: kapusta l. J Clin Oncol. 2000 Dec 15;18(24):4045-52. doi: 10.1200/JCO.2000.18.24.4045. J Clin Oncol. 2000. PMID: 11118465

9

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.

Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Bégin LR, Hamel N, Goffin JR, Wong N, Trudel M, Kapusta L, Porter P, Akslen LA. Foulkes WD, et al. Among authors: kapusta l. Cancer Res. 2004 Feb 1;64(3):830-5. doi: 10.1158/0008-5472.can-03-2970. Cancer Res. 2004. PMID: 14871808

10

Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma.

Merrimen JL, Jones G, Walker D, Leung CS, Kapusta LR, Srigley JR. Merrimen JL, et al. Among authors: kapusta lr. J Urol. 2009 Aug;182(2):485-90; discussion 490. doi: 10.1016/j.juro.2009.04.016. Epub 2009 Jun 13. J Urol. 2009. PMID: 19524976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters